These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23636411)

  • 21. [Botulinum toxin--phenomenon of poison].
    Berny-Moreno J; Barancewicz-Losek M
    Pol Merkur Lekarski; 2006 Apr; 20(118):482-5. PubMed ID: 16886581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of botulinum toxin in blepharospasm and other facial spasms.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oculoplastic experience with the cosmetic use of botulinum A exotoxin.
    Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R
    Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin. The Newport Beach experience.
    Fulton JE
    Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression--An emerging indication for botulinum toxin treatment.
    Kruger TH; Wollmer MA
    Toxicon; 2015 Dec; 107(Pt A):154-7. PubMed ID: 26415901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aesthetic uses of the botulinum toxin.
    Dorizas A; Krueger N; Sadick NS
    Dermatol Clin; 2014 Jan; 32(1):23-36. PubMed ID: 24267419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
    Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
    Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
    Matarasso SL
    Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2007 Dec; 26(4):196-202. PubMed ID: 18395667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine].
    Sommer B; Bergfeld D; Sattler G
    J Dtsch Dermatol Ges; 2007 Feb; 5 Suppl 1():S1-S29. PubMed ID: 17229195
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of botulinum toxins A and B in the treatment of facial rhytides.
    Sadick NS; Matarasso SL
    Dermatol Clin; 2004 Apr; 22(2):221-6. PubMed ID: 15222583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemodenervation for facial dystonias and wrinkles.
    Harrison AR
    Curr Opin Ophthalmol; 2003 Oct; 14(5):241-5. PubMed ID: 14502050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Controversy: botulinum toxin, does it prevent cutaneous aging?].
    Cohen-Letessier A
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
    Blitzer A; Binder WJ; Aviv JE; Keen MS; Brin MF
    Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):389-92. PubMed ID: 9109785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic resistance after repeated botulinum toxin type a injections for facial rhytides.
    Borodic G
    Ophthalmic Plast Reconstr Surg; 2006; 22(3):239-40. PubMed ID: 16714951
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study.
    Keen M; Blitzer A; Aviv J; Binder W; Prystowsky J; Smith H; Brin M
    Plast Reconstr Surg; 1994 Jul; 94(1):94-9. PubMed ID: 8016257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined treatment with botulinum toxin and hyaluronic acid to correct unsightly lateral-chin depression.
    Braz AV; Louvain D; Mukamal LV
    An Bras Dermatol; 2013; 88(1):138-40. PubMed ID: 23539022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.